Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2023 Filed Aug 11, 2023 23:26 UTC |
Stewart MurrayDirector · Interim Chief Medical Officer
|
SaleCommon Stock | 130,056 | $1.06 | $137,859.36 |
DisclosureSEC source: 0001628280-23-029148 · wk-form4_1691796370.xml · nonDerivative · entry 2 Stewart Murray · CIK 0001723450 · Director · Interim Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,504 F2 · kind: Represents nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2023 Filed Aug 11, 2023 23:26 UTC |
Stewart MurrayDirector · Interim Chief Medical Officer
|
GrantCommon Stock | 269,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-029148 · wk-form4_1691796370.xml · nonDerivative · entry 1 Stewart Murray · CIK 0001723450 · Director · Interim Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,560 F1 · shares: Represents shares of common stock acquired upon acceleration of the vesting of a performance-based restricted stock unit grant. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 16:05 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 464 | $1.89 | $876.96 |
DisclosureSEC source: 0001628280-23-024229 · wk-form4_1688587495.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,536 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.84 to $1.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 83,046 shares represent restricted stock units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 16:04 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 2,641 | $1.89 | $4,991.49 |
DisclosureSEC source: 0001628280-23-024228 · wk-form4_1688587453.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,221 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.84 to $1.95 inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents restricted stock units. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 16:15 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 857 | $1.93 | $1,654.01 |
DisclosureSEC source: 0001628280-23-023445 · wk-form4_1687810523.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,000 F1 · shares: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.90 to $1.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 84,624 shares represent restricted stock units. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 16:13 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 5,417 | $1.93 | $10,454.81 |
DisclosureSEC source: 0001628280-23-023443 · wk-form4_1687810394.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,862 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.90 to $1.96 inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents restricted stock units. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:11 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 6,724 | $1.92 | $12,910.08 |
DisclosureSEC source: 0001628280-23-023440 · wk-form4_1687810247.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 543,797 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.90 to $1.96 inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 158,604 shares represent restricted stock units. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 16:24 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 857 | $2.23 | $1,911.11 |
DisclosureSEC source: 0001628280-23-022480 · wk-form4_1686947049.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,857 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.16 to $2.39, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 87,542 shares represent restricted stock units. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 16:17 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 5,417 | $2.22 | $12,025.74 |
DisclosureSEC source: 0001628280-23-022473 · wk-form4_1686946623.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,279 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.14 to $2.39, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents restricted stock units. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:15 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 6,724 | $2.23 | $14,994.52 |
DisclosureSEC source: 0001628280-23-022469 · wk-form4_1686946503.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,521 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.14 to $2.39, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 173,548 shares represent restricted stock units. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:59 UTC |
WYZGA MICHAEL SDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022091 · wk-form4_1686776347.xml · nonDerivative · entry 1 WYZGA MICHAEL S · CIK 0001201256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,667 F1 · shares: Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 21:03 UTC |
MCGIRR DAVID W JDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022093 · wk-form4_1686776597.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,667 F1 · shares: Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 21:10 UTC |
Aliski WilliamDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022099 · wk-form4_1686777025.xml · nonDerivative · entry 1 Aliski William · CIK 0001598426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,667 F1 · shares: Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 21:05 UTC |
Bridger GaryDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022096 · wk-form4_1686776741.xml · nonDerivative · entry 1 Bridger Gary · CIK 0001600049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,667 F1 · shares: Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:57 UTC |
de Craecker FrancoiseDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022090 · wk-form4_1686776222.xml · nonDerivative · entry 1 de Craecker Francoise · CIK 0001887843 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,667 F1 · shares: Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer. Read SEC document |
| June 13, 2023 Filed Jun 14, 2023 20:51 UTC |
Lawton Alison FrancesDirector
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022084 · wk-form4_1686775872.xml · nonDerivative · entry 1 Lawton Alison Frances · CIK 0001542650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,667 F1 · shares: Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer. Read SEC document |
| May 31, 2023 Filed May 31, 2023 21:05 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 6,292 | $1.95 | $12,269.40 |
DisclosureSEC source: 0001628280-23-020355 · wf-form4_168556710981868.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 557,245 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.90 to $2.01, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 188,492 shares represent unvested restricted stock units. Read SEC document |
| March 10, 2023 Filed Mar 13, 2023 16:52 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 18,192 | $0.84 | $15,281.28 |
DisclosureSEC source: 0001628280-23-007724 · wf-form4_167874073622856.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,714 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.82 to $0.89, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 90,458 shares represent restricted stock units. Read SEC document |
| March 10, 2023 Filed Mar 13, 2023 16:50 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 52,500 | $0.84 | $44,100.00 |
DisclosureSEC source: 0001628280-23-007722 · wf-form4_167874064200077.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,696 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.82 to $0.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents restricted stock units. Read SEC document |
| March 10, 2023 Filed Mar 13, 2023 20:48 UTC |
Taveras ArthurChief Scientific Officer
|
SaleCommon Stock | 16,806 | $0.84 | $14,117.04 |
DisclosureSEC source: 0001628280-23-007721 · wf-form4_167874051295561.xml · nonDerivative · entry 1 Taveras Arthur · CIK 0001830901 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,373 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.82 to $0.89, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 51,179 shares represent restricted stock units. Read SEC document |
| March 10, 2023 Filed Mar 13, 2023 20:46 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 49,678 | $0.84 | $41,729.52 |
DisclosureSEC source: 0001628280-23-007720 · wf-form4_167874040015507.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,537 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.82 to $0.89, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 202,474 shares represent restricted stock units. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 17:13 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 4,348 | $0.93 | $4,043.64 |
DisclosureSEC source: 0001628280-23-003758 · wf-form4_167649918418679.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,906 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.92 to $0.98, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 142,958 shares represent restricted stock units. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 17:12 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 27,721 | $0.93 | $25,780.53 |
DisclosureSEC source: 0001628280-23-003757 · wf-form4_167649914450211.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,196 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.91 to $0.98, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents restricted stock units. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:11 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 21,695 | $0.93 | $20,176.35 |
DisclosureSEC source: 0001628280-23-003755 · wf-form4_167649908953055.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,215 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.92 to $0.98, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 312,869 shares represent unvested restricted stock units. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:13 UTC |
Taveras ArthurChief Scientific Officer
|
SaleCommon Stock | 928 | $0.93 | $863.04 |
DisclosureSEC source: 0001628280-23-003759 · wf-form4_167649920502600.xml · nonDerivative · entry 1 Taveras Arthur · CIK 0001830901 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,179 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.92 to $0.98, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 99,679 shares represent restricted stock units. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 16:23 UTC |
DiBiase MaryChief Operating Officer
|
GrantStock Appreciation Right · Derivative | 1,350,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001628280-22-029265 · wf-form4_166802896920270.xml · derivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350,000 Underlying: Common Stock · 1,350,000 shares Expires 2032-11-07 F1 · derivative.exercise_date: The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 16:22 UTC |
Mostafa Adam S.Chief Financial Officer
|
GrantStock Appreciation Right · Derivative | 1,350,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001628280-22-029261 · wf-form4_166802894353588.xml · derivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350,000 Underlying: Common Stock · 1,350,000 shares Expires 2032-11-07 F1 · derivative.exercise_date: The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:22 UTC |
Taveras ArthurChief Scientific Officer
|
GrantStock Appreciation Right · Derivative | 1,000,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001628280-22-029260 · wf-form4_166802891805410.xml · derivative · entry 1 Taveras Arthur · CIK 0001830901 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2032-11-07 F1 · derivative.exercise_date: The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:21 UTC |
Ragan PaulaDirector · President and CEO
|
GrantStock Appreciation Right · Derivative | 3,438,335 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001628280-22-029259 · wf-form4_166802888801839.xml · derivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,438,335 Underlying: Common Stock · 3,438,335 shares Expires 2032-11-07 F1 · derivative.exercise_date: The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:18 UTC |
Baldry MarkChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 341,000 | $1.89 Strike: $1.89 | $644,490.00 |
DisclosureSEC source: 0001628280-22-028462 · wf-form4_166759306432055.xml · derivative · entry 1 Baldry Mark · CIK 0001644137 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,000 Underlying: Common Stock · 341,000 shares Expires 2032-11-03 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on November 3, 2023, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 13:07 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 1,713 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-023325 · wf-form4_166092881804874.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,896 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.150 to $1.215, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 164,504 shares represent unvested restricted stock units. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 13:08 UTC |
Meisner Derek MChief Legal Officer
|
SaleCommon Stock | 8,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-023326 · wf-form4_166092887277332.xml · nonDerivative · entry 1 Meisner Derek M · CIK 0001752461 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,155 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.155 to $1.215, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 13:04 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 10,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-023323 · wf-form4_166092864529306.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,917 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.150 to $1.215, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 17:05 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 13,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-023324 · wf-form4_166092873647049.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,910 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.155 to $1.220, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · acquired: Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award F4 · balance_after: Of the shares of common stock reported, 361,079 shares represent unvested restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 16:56 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 1,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-018397 · wf-form4_165670899460807.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,609 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.88 to $0.92, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 170,338 shares represent unvested restricted stock units. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 17:01 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 2,641 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-018400 · wf-form4_165670924581616.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,751 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $0.88 to $0.92, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 16:09 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-018044 · wf-form4_165636053048715.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,187 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · kind: Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.06 to $1.11, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · balance_after: Of the shares of common stock reported, 171,916 shares represent unvested restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 16:08 UTC |
Meisner Derek MChief Legal Officer
|
SaleCommon Stock | 4,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-018042 · wf-form4_165636047780166.xml · nonDerivative · entry 1 Meisner Derek M · CIK 0001752461 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,489 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.06 to $1.11, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 16:14 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 5,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-018047 · wf-form4_165636087288621.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,392 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.06 to $1.11, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 20:09 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 6,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-018043 · wf-form4_165636050509479.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648,358 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.06 to $1.10, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · acquired: Sale of shares to cover personal income tax obligation upon settlement of restricted stock unit award F4 · balance_after: Of the shares of common stock reported, 390,962 shares represent unvested restricted stock units. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 16:21 UTC |
DiBiase MaryChief Operating Officer
|
SaleCommon Stock | 856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-017435 · wf-form4_165549727289558.xml · nonDerivative · entry 1 DiBiase Mary · CIK 0001880179 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,043 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.03 to $1.12 inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 174,832 shares represent unvested restricted stock units. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 16:22 UTC |
Mostafa Adam S.Chief Financial Officer
|
SaleCommon Stock | 5,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-017438 · wf-form4_165549734296466.xml · nonDerivative · entry 1 Mostafa Adam S. · CIK 0001738081 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,808 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.03 to $1.13, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 16:21 UTC |
Meisner Derek MChief Legal Officer
|
SaleCommon Stock | 4,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-017433 · wf-form4_165549724891007.xml · nonDerivative · entry 1 Meisner Derek M · CIK 0001752461 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,655 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.01 to $1.13, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Represents unvested restricted stock units. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 20:22 UTC |
Ragan PaulaDirector · President and CEO
|
SaleCommon Stock | 6,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-017436 · wf-form4_165549731713465.xml · nonDerivative · entry 1 Ragan Paula · CIK 0001769914 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,082 F1 · date: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.03 to $1.12, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Of the shares of common stock reported, 405,903 shares represent unvested restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 27, 2022 20:16 UTC |
WYZGA MICHAEL SDirector
|
GrantCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018052 · wf-form4_165636098273574.xml · nonDerivative · entry 1 WYZGA MICHAEL S · CIK 0001201256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · balance_after: Represents unvested RSUs. Read SEC document |
| June 06, 2022 Filed Jun 27, 2022 20:10 UTC |
MCGIRR DAVID W JDirector
|
GrantCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018045 · wf-form4_165636062432823.xml · nonDerivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · balance_after: Represents unvested RSUs. Read SEC document |
| June 06, 2022 Filed Jun 27, 2022 20:17 UTC |
Lawton Alison FrancesDirector
|
GrantCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018054 · wf-form4_165636101128022.xml · nonDerivative · entry 1 Lawton Alison Frances · CIK 0001542650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · balance_after: Represents unvested RSUs. Read SEC document |
| June 06, 2022 Filed Jun 27, 2022 20:17 UTC |
Bridger GaryDirector
|
GrantCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018055 · wf-form4_165636102734162.xml · nonDerivative · entry 1 Bridger Gary · CIK 0001600049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · balance_after: Represents unvested RSUs. Read SEC document |
| June 06, 2022 Filed Jun 27, 2022 20:16 UTC |
de Craecker FrancoiseDirector
|
GrantCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018051 · wf-form4_165636096357790.xml · nonDerivative · entry 1 de Craecker Francoise · CIK 0001887843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · balance_after: Represents unvested RSUs. Read SEC document |
| June 06, 2022 Filed Jun 27, 2022 20:15 UTC |
Stewart MurrayDirector
|
GrantCommon Stock | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018050 · wf-form4_165636093576773.xml · nonDerivative · entry 1 Stewart Murray · CIK 0001723450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 F1 · shares: Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · balance_after: Represents unvested RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.